Significantly high levels of anti-dsDNA immunoglobulin e in sera and the ability of dsDNA to induce the degranulation of basophils from chronic urticaria patients

International Archives of Allergy and Immunology

Volumn 161, Issue , 2013, Pages 154-158

  Hatada, Yuko ^a   Kashiwakura, Jun Ichi ^a   Hayama, Koremasa ^a   Fujisawa, Daisuke ^a   Sasaki Sakamoto, Tomomi ^a   Terui, Tadashi ^a   Ra, Chisei ^a   Okayama, Yoshimichi ^a  

^a NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Autologous serum skin test; Autoreactive immunoglobulin E; Chronic urticaria; Mast cells

Indexed keywords

DOUBLE STRANDED DNA; DOUBLE STRANDED DNA ANTIBODY; IMMUNOGLOBULIN E; IMMUNOGLOBULIN E ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY; PEROXIREDOXIN; THIOREDOXIN; THYROGLOBULIN; DNA;

ANTIBODY BLOOD LEVEL; ATOPIC DERMATITIS; BASOPHIL; BASOPHIL DEGRANULATION; CHRONIC URTICARIA; CONFERENCE PAPER; CONTROLLED STUDY; DENSITY GRADIENT CENTRIFUGATION; DISEASE DURATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; SKIN TEST; ADULT; ARTICLE; BLOOD; CHRONIC DISEASE; DEGRANULATION; IMMUNOLOGY; MIDDLE AGED; URTICARIA;

ADULT; BASOPHILS; CELL DEGRANULATION; CHRONIC DISEASE; DERMATITIS, ATOPIC; DNA; FEMALE; HUMANS; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; URTICARIA;

MLCS; MLOWN;

EID: 84880566474     PISSN: 10182438     EISSN: 14230097     Source Type: Journal    
DOI: 10.1159/000350388     Document Type: Conference Paper

References (13)

1. Ferrer M, Nunez-Cordoba JM, Luquin E, Grattan CE, De la Borbolla JM, Sanz ML, Schwartz LB: Serum total tryptase levels are increased in patients with active chronic urticaria. Clin Exp Allergy 2010; 40:1760-1766.
2. Kaplan AP, Joseph K, Maykut RJ, Geba GP, Zeldin RK: Treatment of chronic autoimmune urticaria with omalizumab. J Allergy Clin Immunol 2008; 122:569-573.
3. Saini S, Rosen KE, Hsieh HJ, Wong DA, Conner E, Kaplan A, Spector S, Maurer M: A randomized, placebo-controlled, dose-ranging study of single-dose omalizumab in patients with H1-antihistamine-refractory chronic id-iopathic urticaria. J Allergy Clin Immunol 2011; 128:567-573.e1.
4. Zuberbier T, Asero R, Bindslev-Jensen C, Walter Canonica G, Church MK, Gimenez-Arnau A, Grattan CE, Kapp A, Merk HF, Ro-gala B, Saini S, Sanchez-Borges M, Schmid-Grendelmeier P, Schunemann H, Staubach P, Vena GA, Wedi B, Maurer M: EAACI/GA(2) LEN/EDF/WAO guideline: definition, classification and diagnosis of urticaria. Allergy 2009; 64:1417-1426.
5. Gruber BL, Baeza ML, Marchese MJ, Agnello V, Kaplan AP: Prevalence and functional role of anti-IgE autoantibodies in urticarial syndromes. J Invest Dermatol 1988; 90:213-217.
6. Hide M, Francis DM, Grattan CE, Hakimi J, Kochan JP, Greaves MW: Autoantibodies against the high-affinity IgE receptor as a cause of histamine release in chronic urticaria. N Engl J Med 1993; 328:1599-1604.
7. Fiebiger E, Tortorella D, Jouvin MH, Kinet JP, Ploegh HL: Cotranslational endoplasmic re-ticulum assembly of FcεRI controls the formation of functional IgE-binding receptors. J Exp Med 2005; 201:267-277.
8. Tong LJ, Balakrishnan G, Kochan JP, Kinet JP, Kaplan AP: Assessment of autoimmunity in patients with chronic urticaria. J Allergy Clin Immunol 1997; 99:461-465.
9. Altrichter S, Peter HJ, Pisarevskaja D, Metz M, Martus P, Maurer M: IgE-mediated auto-allergy against thyroid peroxidase-a novel pathomechanism of chronic spontaneous urticaria? PLoS One 2011; 6:e14794.
10. Konstantinou GN, Asero R, Maurer M, Sa-broe RA, Schmid-Grendelmeier P, Grattan CE: EAACI/GA(2)LEN task force consensus report: the autologous serum skin test in urticaria. Allergy 2009; 64:1256-1268.
11. Gentinetta T, Pecaric-Petkovic T, Wan D, Falcone FH, Dahinden CA, Pichler WJ, Haus-mann OV: Individual IL-3 priming is crucial for consistent in vitro activation of donor ba-sophils in patients with chronic urticaria. J Allergy Clin Immunol 2011; 128:1227-1234 e1225.
12. Okumura S, Kashiwakura J, Tomita H, Mat-sumoto K, Nakajima T, Saito H, Okayama Y: Identification of specific gene expression profiles in human mast cells mediated by Tolllike receptor 4 and FcεRI. Blood 2003; 102: 2547-2554.
13. Gimborn K, Lessmann E, Kuppig S, Krystal G, Huber M: SHIP down-regulates FcεR1-induced degranulation at supraoptimal IgE or antigen levels. J Immunol 2005; 174:507-516.